Learn about the latest research studies on different treatments for women with breast or cervical cancers from Associate Professor Dr. Yoland Antill. Some of the results of these research studies may offer you more choices when it comes to discussing treatment options with your medical professionals.
Dr. Yoland Antill is a Medical Oncologist and Cancer Genetics specialist from the Australia and New Zealand Gynaecological Oncology Group (ANZGOG) Research Advisory Committee. She has over 20 years of experience in oncology and cancer genetics within both the public and private sectors.
In this episode, Dr. Antill discusses in simple to understand language, the results of various research studies that were conducted into the varying treatments for both cervical and breast cancer patients. With this knowledge, you will be better equipped to discuss your own personal treatment with your medical team and ask about the various options available.
Additional Resources:
Congress For Patients website:
https://congressforpatients.com.au/
SHAPE trial on cervical cancer surgery:
https://ascopost.com/news/june-2023/simple-hysterectomy-may-be-a-safe-option-for-patients-with-early-stage-low-risk-cervical-cancer/
https://ascopubs.org/doi/abs/10.1200/JCO.2023.41.17_suppl.LBA5511
Results from trials conducted on treatments for small node-negative HER2+ breast tumors:
https://www.researchgate.net/publication/371296496_Outcomes_according_to_treatment_received_for_small_node-negative_HER2_breast_tumors_in_the_Surveillance_Epidemiology_and_End_Results_SEER_database_2010-2019
Information about CDK4/6 inhibitors:
https://www.breastcancertrials.org.au/cdk-4-6-inhibitors/
Outcomes from the phase 3 SONIA trial for patients with hormone receptor-positive or negative breast cancer:
https://ascopubs.org/doi/abs/10.1200/JCO.2023.41.17_suppl.LBA1000
Effects of ovarian ablation or suppression on breast cancer recurrence and survival:
https://meetings.asco.org/abstracts-presentations/218409
Evaluation of PAM50 intrinsic sub-types and risk of recurrence in premenopausal women with early-stage HR+ breast cancer:
https://ascopubs.org/doi/abs/10.1200/JCO.2023.41.16_suppl.504
Podcast produced by East Coast Studio
See omnystudio.com/listener for privacy information.